Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Vincent

Neurological Surgery Virginia Beach, VA Medical Doctor

NPI 1477552552 CMS profile 202904

5716 Cleveland St Ste 200, Virginia Beach, VA 23462

Open in the dashboard

General payments

$958,919

122 records reported · program years 2019–2025

Research payments

$3,000

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, David Vincent of Virginia Beach, VA is reported in the CMS Open Payments database as having received $958,919 across 122 general payments and $3,000 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $172,120 32
2024 General $173,818 20
2024 Research $3,000 1
2023 General $172,692 13
2022 General $148,431 11
2021 General $138,772 10
2020 General $102,742 16
2019 General $50,343 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Vincent
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to David Vincent were reported at $172,120. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year David Vincent Neurological Surgery median Middle half National median
2019 $50,343 $582 $138–$3,006 $163
2020 $102,742 $294 $76–$2,174 $114
2021 $138,772 $387 $105–$2,432 $132
2022 $148,431 $542 $139–$2,989 $149
2023 $172,692 $534 $145–$2,697 $160
2024 $173,818 $574 $155–$3,046 $164
2025 $172,120 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alphatec Spine, Inc $769,188 42 payments
  2. NuVasive, Inc. $147,900 20 payments
  3. Globus Medical, Inc. $33,973 20 payments
  4. Arteriocyte Medical Systems, Inc. $2,813 4 payments
  5. TrackX Technology, LLC $2,383 5 payments
  6. Intrinsic Therapeutics $1,526 8 payments
  7. Providence Medical Technology, Inc. $457 2 payments
  8. Innovation Technologies Inc $168 3 payments
  9. Relievant Medsystems, Inc. $101 1 payment
  10. Integra LifeSciences Corporation $76 2 payments
  11. Other $334 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $938,323 59 payments
  2. Consulting Fee $12,675 8 payments
  3. Food and Beverage $4,242 50 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,100 1 payment
  5. Travel and Lodging $1,475 3 payments
  6. Entertainment $105 1 payment
Products named General payments · program years 2019–2025
  1. Invictus MIS $639,345 19 payments
  2. LessRay Spine/Spine Surgery $75,026 11 payments
  3. CoRoent Spine/Spine Surgery $74,229 16 payments
  4. Armada Spine/Spine Surgery $69,345 10 payments
  5. LessRay Spine/Spine Surgery $60,095 6 payments
  6. Armada Spine/Spine Surgery $55,673 6 payments
  7. Other - Miscellaneous $52,352 7 payments
  8. Invictus OPEN $48,978 14 payments
  9. CoRoent Spine/Spine Surgery $48,824 5 payments
  10. IdentiTi $28,013 1 payment
  11. Other $27,912 65 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Intrinsic Therapeutics $3,000 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

187

Median for Neurosurgery: 83

Drug cost

$1,070

Median for Neurosurgery: $872

Branded share of claims

32.1%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 44 $311
Gabapentin Generic 19 $162
Tizanidine Hcl Generic 30 $162
Oxycodone Hcl Generic 24 $141
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 16 $116
Methocarbamol Generic 38 $107
Methylprednisolone Generic 16 $72

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$321,522

Medicare's payments for the services billed

Medicare patients

422

Average age 74

Services billed

1,252

217 women, 205 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 26%
Depression 26%
Ischemic heart disease 24%
Chronic kidney disease 21%
Osteoporosis 19%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

123 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record